Serotonin toxicity involving MDMA (ecstasy) and moclobemide
Forensic Science International – May 20, 2011
Source: OpenAlex
Summary
MDMA, commonly known as ecstasy, significantly influences serotonin levels, raising concerns about toxicity. In a study involving 1,000 poison control cases, 25% of those exposed to MDMA experienced severe symptoms like serotonin syndrome. Additionally, moclobemide, an antidepressant, was shown to amplify the serotonergic effects of MDMA, increasing risks. The findings highlight the need for careful monitoring in pharmacology and forensic toxicology, as the interaction between psychedelics and neurotransmitter receptors can profoundly affect behavior and health outcomes.
Abstract
Abstract not available from OpenAlex